Page 76 - Sohini Das

New-age pharmacy start-ups tap 'kirana' networks, eye US market

New entrants in the largely unorganised Indian pharmaceuticals market are trying out innovative ways to tap a vast market that lies in hinterland

WHO technical advisory group to take call on Covaxin EUL next week

Vaccine maker presented data before SAGE working group on Tuesday

Syringe makers expect export of items with low demand in India to continue

Industry estimates India has stockpile to last about a month for Covid-19 vaccination

States not on same page as govt gears up to roll out digital health mission

Tamil Nadu plans parallel programme with unique user IDs

Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India

Only 3 firms - Novo Nordisk, Sanofi, and Eli Lilly - supply insulin to patients in the US. These three companies, commonly called the 'Big Three', control over 90 per cent of the global insulin market

Bharat Biotech injects pace into Covid-19 vaccine Covaxin supply

Constraints on the availability of India's first indigenous Covid-19 vaccine could end soon

Bharat Biotech likely to start manufacturing Covaxin at Pune plant soon

Animal vaccine maker Hester Biosciences, on the other hand, is setting up a greenfield BSL-3 facility in Gujarat to make Covaxin

India warns of 'reciprocal measures' if UK doesn't recognise Covishield

India on its part does not insist on vaccination and has done away with institutional quarantine for foreigners entering the country

India to resume export of Covid vaccines from October: Mansukh Mandaviya

Sources say the Centre has been working to create a stockpile of vaccines for India in case a third wave strikes

Mylab picks up majority stake in point-of-care testing firm

Sanskritech has develop a point of care testing platform Swayam that can do 70 tests on the spot

In flu season, virus symptoms spark Covid 3.0 fear among kids

But post-monsoon, some clinicians have noticed a surge in paediatric Covid cases.

Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed

Says confident of resolving matter, does not share nature of observations

Covid-19 vax export curbs may ease in two months: Adar Poonawalla

Poonawalla said easing the export restrictions is a government of India's decision, and he will go by what the Centre feels is appropriate

Biocon Biologics, Serum Institute Life Sciences enter strategic alliance

Work on mRNA platform, antibodies for dengue, HIV in the plan

Biological E gets approval to manufacture J&J Covid-19 vaccine in India

According to sources, discussions are on between J&J and the Centre on the matter of indemnity against any serious adverse effect after vaccination

Asia Healthcare-backed single-specialty clinics grew during pandemic

AHH now plans to make similar investments with focus on nephrology, gastroenterology, and ophthalmology among others

Gennova's mRNA vaccine to come in powder form; will stay stable at 2-8 °C

The lyophilized vaccine will come in a powder form and it will be mixed with diluents before administration

Syringe makers ramp up production, fear demand may soon outstrip supply

The Centre is looking to procure around 1 billion syringes between September and December to support the Covid-19 vaccination drive

Corporate hospitals expect double-digit revenue growth in FY22: Icra

Blended occupancy of Covid and non-Covid patients was 64.2% in Q1FY22 as against 36.9% in Q1FY21 and 58.8% in Q4FY21. Therefore, the growth is not just on a low base, but also sequential

Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs

Lupin working on remdesivir powder inhaler; Glenmark to do trials on Nitric Oxide Nasal Spray